BOOK REVIEW
Redefining Health Care
by
Michael E. Porter & Elizabeth O. Teisberg
Page Contents
FUTURECASTS online magazine
www.futurecasts.com
Vol. 9, No. 10, 10/1/07
The Need For Health Care Reform
The third party payer system mess:
& |
The fundamental task of delivering value to the
patient is in conflict with all the economic incentives in the current
health care system, Michael E. Porter and Elizabeth O. Teisberg emphasize at the
beginning of "Redefining Health Care: Creating Value-Based Competition on
Results." It is this that leads to the dysfunctional results so
increasingly evident. & |
There are "not just skewed regulatory and private sectors incentives, but also a fundamental misalignment between the nature of competition and value for the patient" in the current health care system. |
Moreover, neither of the broad reforms currently most
widely advocated - universal health coverage or methods of empowering consumers
- can in their present form address the pertinent complex of problems. |
Other countries are moving away from their universal, single payer systems. |
A brief review of current problems is provided by
the authors. Despite spending almost $2 trillion on health care as of 2006 and
the capacity to achieve remarkable health care outcomes, the system suffers from
large variations in the quality of care delivered, high error rates, the
delivery of both too much and too little care, and all the problems of a mass
medicine system. To access the required levels of care frequently requires
determined efforts by patients and their families. Moreover, costs that are
rising rapidly and inexorably threaten all the parties involved. Bureaucratic
efforts to administer the system are strangling it.
Health savings accounts ("HSA"), government
entitlements to cover drug costs, and the spread of information technology, may
all be helpful, but all fail to address the complex underlying problems. Large
integrated systems lack the needed forms of competition. Consumers, no matter
how empowered, will frequently remain at a disadvantage when accessing the
complex and arcane health care market. Other countries are moving away from
their universal, single payer systems. There must be fundamental changes for all the participants in the health care
system if the problems are to be effectively dealt with. |
The structure of the health care delivery system is the starting point for the authors. Structure drives cost and quality, which impacts insurance premiums and the amount of coverage feasible.
|
Competition in the health care system does
none of these things. Health care competition is today dysfunctional.
Costs rise and quality varies widely, quality service is not rewarded, and
weaker providers don't go out of business. Innovation diffuses slowly and
doesn't drive value improvement the way it should.
|
|
Misaligned incentives and prior strategic choices affecting all participants have created this "dysfunctional competition." Some large integrated participants like the Veterans Administration hospitals, Intermountain Health Care, and Kaiser have avoided this dysfunctional competition and achieved remarkable results. However, limiting competition is not the answer.
|
Competition Based On Patient Outcomes
Value for patients: & |
System participants should
be competing on the basis of the value they deliver to patients instead of
battling over who pays what and the achievement of short term goals. & |
The relevant factors today are inputs when they should be outcomes.
Real competition is stifled by confining patients to health plan networks, captive referrals within provider groups, and a lack of relevant information. |
None of the reforms, past or currently advocated, is designed to stimulate competition to deliver superior value for patients. Indeed, many create incentives that are badly misaligned with value for patients.
Competition is currently in different ways "too broad, too narrow, and too local." The relevant factors today are inputs when they should be outcomes. The focus is on discreet interventions instead of on the full cycle of care. The care provided for individual medical conditions involves fragmented interventions instead of an integrated approach. Value for the patient involves the full cycle of care, not just the outcome of a single intervention, office visit or test.
Real competition is stifled by confining patients to
health plan networks, captive referrals within provider groups, and a lack of
relevant information. The patient faces a sometimes insuperable challenge in
navigating the system. There is little guidance in the avoidance of unneeded
interventions. There is little help in preventing disease or managing ongoing
problems. |
The localized structure of health care services
has been rendered obsolete by the increasing complexity of health care
services and the increasing ease of travel. Local providers frequently lack the
volume and experience to develop excellence for particular conditions. Expensive broad-scale facilities
frequently lie idle. Supply frequently "creates" its own demand as
providers order tests and - worse - perform interventions that are not needed in
order to justify over-expanded capabilities. |
Superiority of competition on results: |
Value to the patient depends on
"patient outcomes per unit of cost at the medical condition level."
Competition on this basis can be a winning proposition for all participants in
the system. However, it requires that results be measured and disclosed. & |
"The ability to measure results and to control fairly for initial patient circumstances" - to adjust for risks - has in fact been "conclusively demonstrated" the authors assert. Yet today no system participants require it or do it.
Instead, the effort has been to control supply and micromanage provider practices - to set procedural standards of care and to review requirements for new capital investment.
|
Any reform that doesn't involve value-based competition will fail to control costs or provide incentives for excellence. |
Instead of setting minimum standards that all can
meet, it is essential that the better providers be recognized so patients
can migrate towards them to apply pressure for innovation and excellences across
the whole system. Any reform that doesn't involve value-based competition will
fail to control costs or provide incentives for excellence. |
In properly
functioning competitive markets, competition is a positive sum game where
all customers receive higher quality and greater choice for reduced sums,
markets expand and quality producers prosper while those that provide inferior
goods and services are pushed aside. (These benefits flow in abundance even when
competition is far from "perfect.") |
In zero-sum competition -
such as currently in health care - the financial pie doesn't expand. It is just
repeatedly divided as participants fight over shares. Value to customers plays
no role. Instead of striving to attract customers by creating value for them,
participants struggle to shift costs and to capture customers by restricting
choice, and to reduce costs by restricting services.
|
|
Dysfunction pervades the current system. The
incentives of the current system raise costs while reducing the quality of care. |
Competition for resources among participants does not focus on outcomes or even on overall costs. It permits providers with worse outcomes and higher costs to stay in business. Competition focused on patient outcomes "would drive improvements in efficiency, effectiveness, reduce errors, and spark innovation." Unfortunately, there is now almost no competition at the level of medical condition outcomes. Physicians and patients are generally confined within network practice. There is practically no information about comparative capabilities.
|
|
Inevitably, health plans and providers are driven to
restrict treatment options to cut costs. This is clearly counterproductive
for the patient. "De facto rationing" has thus become disturbingly
widespread.
There simply are no incentives at present for referring
patients to the best providers - or knowledge as to who those providers may be.
There are strong incentives for not going beyond network providers. Even for
Medicare patients who have no network limitations, referrals are generally
restricted to local providers because of habit, inertia and lack of
information. |
Broad line providers stretch to provide services
for which they have insufficient volume to achieve expertise and efficiency. For
example, there were 139 hospitals offering heart transplant service, although
many see only a few patients per year and have even fewer who survive. On the
other hand, this supply often creates its own demand as providers stretch to
utilize the diagnostic and treatment facilities they have whether or not the
services are needed.
|
|
Cosmetic surgery is not substantially afflicted by
third party payer systems. In that field, for example, quality improves and
costs decline.
The use of buying groups to obtain discounts for supplies
often results in large inventories of some items and shortages of others - and
long delays in acquiring innovative products. Drug companies now spend large
sums advertising their products to potential patients. All of this, of course,
has to be paid for. |
The need for focus on patient outcomes:
& |
Competition has to be focused
on services for the patient. It should be focused on "addressing
particular medical conditions" over the full cycle of care, "including
monitoring, diagnosis, treatment, and ongoing management of the condition."
This requires information about actual experience levels, treatments used, prices
and results. & |
Performance information is essential for such competition. Performance information stimulates quality improvements and controls costs. However, it is largely lacking in the current system. Indeed, pricing regulations have become so "Byzantine" that many providers couldn't quote a price if they wanted to. "Patient satisfaction" data is useful but clearly not specific enough. Ranking systems are not evidence based and have many inadequacies.
One study of results showed that death rates among stroke
patients varied from zero to 36.8%. Clearly, such information is vital. In
Pennsylvania, a study of heart valve replacement procedures showed that the most
expensive hospitals had the worst results. Without such information, the primary
disciplinary factor is law suits rather than competition. This, too, drives up
costs. |
|
Some reporting systems have been established with major immediate benefits.
A variety of organizations have been established to
provide outcome data for specific ailments. United Resource Networks specializes
in organ transplants. Preferred Global Health covers Europe and the Middle East. |
Administered Health Care Systems
Health plan reforms:
& |
The authors repeat and elaborate all the
problems of the health care system as they affect health plans, and then
explain how to reorganize for success based on subscriber health outcomes
instead of the mere cutting and shifting of costs. Reorganizing for value-based
competition on results over the full cycle of care requires medically integrated
care rather than "focused factories delivering specific procedures or
piecemeal care." & |
The history and development of the current dysfunctional third party payer system and the inevitably counterproductive administered alternatives to market pricing mechanisms that have been tried are described at some length. This is recommended reading as an example of the law of complex systems. Every reform quickly resulted in a multitude of unintended consequences, some of which inevitably made matters worse. Further reforms just repeated this cycle. The multiplication of unintended consequences by the series of reform efforts ultimately creates an impossible situation.
National health care systems in other countries are now experiencing alarming increases in health care spending and are resorting to various forms of rationing. The evidence is that the quality of care is frequently inferior to the U.S. system and the rates of medical error are higher.
|
Single payer national systems are now being viewed by many as the ultimate reform, and they do offer many theoretical possibilities for administrative simplicity and cost reduction. However, they destroy all competition, ration care to control budgets, deter innovation, and may kill the market for the development of new drugs. A national single payer system is the ultimate incentive for zero-sum competition.
|
|
Health savings accounts and other incentives for
active "consumer" choice are viewed by the authors as useful steps in
introducing the right kind of competition into health plans, but alone they do
not go far enough. Health care consumers are still restricted to insurance or
health plan options that are currently enmeshed in networked systems and engaged
in dysfunctional forms of competition. Consumers are still left with the
daunting task of making a series of appropriate decision over the full cycle of
care on the basis of grossly inadequate information. Value based competition
focused on the patient's particular medical condition over the full cycle of
care creates positive incentives that eliminate these problems. |
Pay for performance and similar recent quality-focused reforms are actually about process rather than quality. |
Pay for performance and similar recent quality-focused reforms are similarly viewed as useful but clearly insufficient. They
are actually about process rather than quality. Most are really "pay for
compliance" with accepted medical standards of practice. "Providers
are expected to conform to specific processes, but are not necessarily
rewarded for better results." (emphasis in original)
|
Extending tax deductibility to insurance premium payments by individuals does not address either cost or quality issues. Entitlement expansion and the purchase of drugs from Canada are just more cost shifting exercises that increase incentives for zero-sum competition. Purchase of drugs from abroad could destroy market justification for the development of new medicinal drugs. |
Meaningful Competition in Health Care
Value-based competition on results: |
Positive-sum
competition is created by value-based competition on results. All
participants can win, although the least competent will be pushed aside as the
most capable expand. & |
Value-based competition on results is "the only way to drive sustained improvements in quality and efficiency."
|
The authors identify the primary characteristics for
value based competition.
Value for the patient - patient outcome - is a subjective standard. Different patients may value various outcomes differently and be willing to accept different degrees of risk. Some may prefer less aggressive treatment than others. No top-down system can deal with such variations. A competition-based system automatically takes such factors into account where a centrally managed system provides one-size-fits-all procedures.
|
|
To compete in this manner, providers will have to organize themselves to deal with and specialize in entire medical conditions - not just discreet interventions, treatments or services. This team approach with joint responsibility offers many opportunities for improvements in health care.
Such management can prevent early stage illness from
progressing into more severe stages. Early stage kidney disease, for example,
may be prevented from progressing into kidney failure. Yet, preventive health
care measures are not generally a part of the current system.
The authors note a study that revealed that a new more expensive
diuretic drug frequently resulted in worsened outcomes. However, this outcome was
not widely known. |
Scale is important in providing financial support for
teams and facilities dedicated for particular medical conditions. "Scale
results in multiple colleagues doing similar things who can consult with and get
feedback from one another." The authors cite the orthopedic surgeons at New
England Baptist Hospital.
|
|
Fragmentation of services in full service health care facilities results in "subscale services, dependence on less dedicated resources, shared facilities, quality problems, and inefficiency." Unfortunately, the current system rewards such inefficiency. |
But there has to be the right kind of competition. There has to be several
competing providers specializing in treatment of each medical condition,
otherwise complexity and complacency and repetition of conventional procedures
may set in.
|
The authors note that improvements in the treatment of
certain medical conditions - like coronary heart disease and gall stones - have
resulted in reduced costs rather than increased costs. A diagnosis that leads to
ineffective treatment is no bargain, while high-cost stroke intervention that
avoids long nursing home confinement is a bargain. |
|
The results that count are not reputation or amenities or results of discreet procedures, but the results for the specific medical condition over the full cycle of care. To develop such information will require patient tracking systems.
|
Information about results - about costs and treatment outcomes
adjusted for risks and measured over the full cycle of care - is vital for
effective competition. Patient choice and evaluation of providers must be based
on reliable information.
|
|
Standardized medicine is not the goal, the authors emphasize.
Innovation and rapid diffusion of best practice advances is the intermediate
goal. The true goal is improving risk-adjusted results over the full care cycle.
Indeed, when results are accurately reported, the reporting of process
information will be unnecessary. Collection of process information, of course,
will still be a part of internal quality control and improvement efforts. |
|
The measurement and reporting of experience with particular medical
conditions is more straightforward than for methods and results. It is a fair
but not perfect proxy for results expectations. Experience reports should be
systematically broken down with relation to treatment approach, disease
subtypes, patient populations -- age and risk factors -- complications, initial
conditions, etc. Eventually, genetic data will be included.
Health plans fear that patients will demand the most
expensive treatment. This fear too has proven unfounded. "Empirical
evidence shows that informed patients tend to choose less invasive, less
expensive care and achieve better outcomes."
|
Innovation studies have to be expanded to examine the results of full care cycle outcomes and various aspects of care besides drugs and surgical implants. At present, there is little incentive for such studies, yet changes in organization and processes have provided major improvements in care. The authors provide several examples. Competition on value would provide such incentives. The measurement of risk-adjusted outcomes facilitates such studies.
|
|
The ability to deal with severe stroke victims varies widely among
hospitals, the authors point out. Getting to the right hospital within the first
3 hours can be critical. Trauma centers offer another example of the superiority
of dedicated facilities. For less time-sensitive conditions, competition
can be national or even international. Yet, the current system does not
disseminate information about such specialized capabilities and poses obstacles
to going beyond local or network facilities.
A general hospital is needed for emergency care, routine and
preventive care, disease management, and follow-up care. For complex medical
conditions, they should have relationships with specialized providers unless
they have the scale to create their own dedicated teams. |
Organizing for effective competition: & |
To prepare for value-based
competition, healthcare providers must systematically identify and analyze
the health care processes they offer and related developments in the field,
adapt information technology to support those processes, and systematically
examine the results of those processes at the medical condition level. & |
Not-for-profit organization with a well-meaning service orientation is often an obstacle to reform. |
Most important is the removal of barriers to change, ranging from entrenched organization elements and mind-sets to obsolete regulations and counterproductive reimbursement models. Many providers succumb to inertia. They will be left behind. Not-for-profit organization with a well-meaning service orientation is often an obstacle to reform.
The organization dictated by current reimbursement models and the
desire of individual physicians to engage in a varied practice also create
barriers to effective focus. |
The dramatic increase in the number and complexity of health care services renders unfocused methods obsolete and even dangerous to patients.
Rather than breadth of services, providers should have a breadth of alliances and associations with other specialized providers. |
Hospitals, physician groups and individual physicians need to focus their practice. They have to define purpose and goals, the medical business they will operate in, the service they will offer, and how they will distinguish themselves from their peers. It is focus that provides direction to attain "true excellence."
Clear goals will determine organizational structures, measurement
systems, and facility usage. Current full-service and traditional broad practice
provide none of this. The dramatic increase in the number and complexity of
health care services renders unfocused methods obsolete and even dangerous to
patients. Lack of focus undermines skill levels and generates excess capacity in
underutilized facilities and equipment - the cost of which has to be passed on
to all patients. |
The complexity of today's health care requires integrated teams specializing in particular medical conditions. |
Focus on particular medical conditions can guide integration of various types of care givers into appropriate teams specializing in those medical conditions throughout the cycle of care. At present, care is fragmented.
Traditions of separate individual specialties and professional
independence arose in simpler times. The complexity of today's health care
requires integrated teams specializing in particular medical conditions.
"To be strategic, providers will need everyone involved in care delivery to
have a common goal centered on the patient, and a shared commitment to overall
results, not individual agendas." |
To achieve adequate scale to justify dedicated staff and
facilities, providers must compete over broader geographic areas. Modern
transportation facilitates such broadening of service areas. Excellence will
draw patients regionally or even nationally and internationally. Partnerships
with other specialized providers should be formed equally broadly.
To achieve this, hospitals, physician groups and even individual physicians must develop their practice around particular medical conditions in which they can specialize and achieve excellence. "The business is congestive heart failure, for example, not heart surgery, cardiology, angiography, or anesthesiology."
|
|
The choice of the range and types of services provided is the key strategic decision. This must depend on the mix of patients, provider skills, facilities, and cost base, among other factors.
While an array of services will be offered by most hospitals,
competitive pressures will ultimately run against attempts to offer everything.
When information about results becomes available, there will be accountability
for performance that will force withdrawal from poorly performed services. |
Specialization initiates a virtuous circle starting with
quality improvements that result in enhanced reputation, greater patient flow,
and many other benefits. "The huge variations in performance across
providers reveal the magnitude of the opportunity" for developing
specialized medical condition expertise. |
|
The vertically integrated provider-HMO organization model is viewed as a second-best solution. Such organizations look attractive only because of the flaws in the current system.
|
"The integrated practice unit" is the team organized to treat particular medical conditions.
Most providers will operate multiple units for those medical
conditions for which they have sufficient scale and expertise. They probably
shouldn't be practicing medicine in other lines. |
|
The IPU model provides multidisciplinary resources for diagnosis,
treatment and disease management. However, the focus is on best practices in
delivering care - not the procedure offered by particular skills. They cover
common complications and medical conditions that require similar treatment
skills, facilities and care delivery approaches. They should encompass the full
cycle of care.
Ultimately, IPUs form hospitals within hospitals and practices within
practices. |
Benefits of the team approach begin with diagnosis. With more
people involved in diagnosis, more experience is brought to bear and accuracy
should be improved. Mistakes in diagnosis can be costly. Often, diagnosis is
influenced by what a particular doctor is set up to treat. Diagnosis can be
iterative, and can change as treatment is attempted. |
|
Urban community hospitals and rural hospitals should
concentrate on the medical conditions for which they have sufficient volume. For
other conditions, they should have "medically integrated
relationships" and even partnerships with excellent providers to whom they
refer patients. They will of course still provide emergency care and diagnosis
and treatment of relatively common conditions. They will also provide follow-up
care and disease management for chronic conditions. By closing low volume
service lines, they will reduce costs and increase resources for what they do
best. |
Examples of providers that have moved towards the IPU model are
provided by the authors. |
|
The volume achieved by these units supports their dedicated facilities and staffs. With measurement of results, they achieve constant improvements in techniques. Various methods are used to involve the units in the full cycle of care, but this is still an evolving area.
The ultimate goal is to have patient-centered care for particular
medical conditions dedicated and integrated over the cycle of care. However,
specialization should go even further. Medically centered care units should
develop elements of expertise that distinguish them from similar units.
Concentration can focus on complex diagnoses, serving particular patient groups
by gender or age that experience co-occurring conditions, offering extraordinary
timeliness or efficiency or excellence in particular treatments or disease
management. |
Measuring and reporting results:
& |
Measurement of results is the key to improving care techniques,
reducing costs, and marketing services. Providers are in fact increasingly being
driven to measure and report results. However, this must not be focused just on
good practices or hospital-wide results. It should be focused on health outcomes
for particular medical conditions over the full cycle of care. & |
The focus has been less on understanding and reducing costs than on learning to bill creatively to maximize revenue.
Even initial steps at outcomes measurement have yielded startling benefits for patient care. |
Costs and pricing information, provider volume and experience, methods and patient characteristics also constitute important information that should be clearly measured and reported. This will be a complex and varied undertaking, and the authors go into it in some detail. Individual IPUs as well as medical boards and societies should all be involved in developing measurement standards. General categories of information include outcome measurements - complications, errors and failed treatments - diagnostic accuracy - patient registries to facilitate tracking of long term outcomes - and patient feedback. Cost data pertinent to IPU activity over the care cycle should also be measured and reported.
Only by combining relevant cost data with patient outcome data and patient characteristics can true value for patients be determined. An outline of the clinical and outcome information collected by the Boston Spine Group is provided as an example. However, this type of information has not been widely collected for a wide variety of reasons. This should all change as practice unit structures are developed and begin to compete on the basis of value delivered to patients.
ThedaCare and Sentara collect outcomes data on individual physicians.
Even initial steps at outcomes measurement have yielded startling benefits for
patient care. The Cleveland Clinic is moving to require all clinical departments
to develop and publish outcomes data. The authors provide Cleveland Clinic
reports and excerpts in an appendix to the book. Other hospitals are following
suit. This supports their marketing efforts by demonstrating their commitment to improvement and patient value. |
Billing practices: |
Providers have to change their billing practices.
The patient must receive a single bill that can be priced in advance for each
care episode or cycle. & |
The current system has been misshaped - like so much else - in
response to the reimbursement practices of third party payers - primarily
Medicare. With rising deductibles and expanding use of health savings accounts,
providers are going to increasingly have to respond to the patients themselves.
Health plans and employers, too, are likely to increasingly want single, unified
bills. This will beneficially force doctors and hospitals to work more closely
together in pricing and integrating services.
|
Marketing: |
The focus of health care marketing must be practice
unit excellence. & |
Reputation plus breadth of services, convenience, external referral
relationships and word of mouth are inferior or at best secondary factors to
patients. Concrete evidence on experience and results will attract patients, but
is today mostly lacking. Instead of mere general claims, providers "should
begin to disseminate the information patients really want -- their experience,
expertise, methods, and results." |
Expansion:
& |
Individual practice unit expansion opportunities lie
in two geographic directions. The first is deeper penetration of a local market
based on superior outcomes for patients with particular medical conditions. & |
Then, there are opportunities for broader geographic expansion. There are regional, national and even international expansion opportunities. With expansion comes the opportunity to "leverage scale, expertise, care delivery methods, staff training, measurement systems, and reputation to serve more patients."
Expansion by a mere increase in the range of services offered
locally has little to do with patient value, and will be a losing strategy in
competitive health care markets. Services that lack the scale to support
experience and develop excellence will lose out to individual practice unit
competition as it expands into local markets. There are only limited
opportunities for synergies from expansion of services offered, and that is just
a one time benefit. |
|
Rural hospitals can participate through geographic integration
models encompassing contiguous rural regions and through regional centers. "There is
no reason that rural institutions, through medical integration and careful
choice of partnerships in complex practice units, cannot offer truly world-class
care at high levels of efficiency to their communities." Primary care
practice "will increasingly become the front end and the back end of
integrated care cycles."
|
Reorganization for Value-based Competition
Effective competition: |
A transformation based
on IPUs organized around specific medical conditions is required for
effective value-based competition The authors offer an extensive outline for how
current systems can transform themselves. & |
A "Care Delivery Value Chain" is described for
restructuring IPUs. It is an analytical tool producing customized results for
different medical conditions and classes of patients. It is not a rigid framework.
Support activities - including contracting, billing, facilities management,
etc., have to be configured for the purposes of the practice units and medical
conditions. & Care delivery value chains begin with monitoring and prevention, then continue through diagnosing, preparing, intervening and rehabilitating. How patients access and move through the system, how their conditions are measured, and how patients are informed and educated are concerns throughout the value chain process. There are feedback loops at every stage of the value chain based on patient condition and response.
Just engaging in the value-based competition transformation exercise
can rationalize the care giving process with major improvements in efficiency
and in health care outcomes. The authors provide extensive guidance in this
important process. |
|
Harnessing the power of information technology is a vital part
of this process - not just for billing and records but as "a platform for
integrated, results based management." This requires the patient-centered
organization of data. Information "silos" are of little utility. The
integrated practice unit and the medical condition are the units for the
aggregation of information. Thus, the practice unit must be involved in the
design of the system. Rolling out the system in logical stages is also vital.
The Cleveland Clinic information technology infrastructure is cited as an
example.
|
Barriers to value-based competition: |
Third party payer
reimbursement practices and federal and state regulations create major
barriers and disincentives for the development of value-based competition. & |
Vested interests in the current system and simple inertia also make change difficult. A shortage of management skills within health care providers makes any change a challenge.
Professional attitudes also create obstacles. Professional independence is prized, and physicians want to handle an array of cases.
|
|
Examples of how these obstacles are being overcome in both
health care practice and medical education are provided by the authors.
& |
Third party payers: |
It is in the interests of third party payers
to encourage and support the transformation to value-based competition. & |
This will require significant changes in their attitudes and reimbursement practices. They, too, must refocus on health value for patients rather than on just reimbursement for costs. Major benefits for both cost containment and member health will flow naturally from that change. For private health plans, the transformation will also create substantial competitive advantages.
|
There are tremendous cost savings available from the simplification of the administrative procedures of both payers and providers, and from the achievement of superior health outcomes. The authors explain and earnestly advocate the desired changes. The current top-down regulation of processes is a losing and ultimately costly approach.
|
|
Pay for performance rewards are always higher payments when they should be increased patient flow and greater margins from efficiency and expertise. |
Current "pay-for-performance" policies concentrate on
practices rather than results. The reward is always higher payments when it
should be increased patient flow and greater margins from efficiency and
expertise. |
Here, too, it is competition that will ultimately drive these reforms. The authors provide an extensive outline of the measures health plans can take to shift to value-based competition. They are similar and complimentary to the steps advised for health care providers. They involve multiyear subscriber contracts as a basis for involvement in full cycle care for particular medical conditions, including "providing health information, counseling, and ongoing support to members." Indeed, they should develop specialized health condition management units and subunits for reasons similar to those supporting the development of provider IPUs.
|
|
Information collected over the full cycle of care will reveal the most skilled diagnosticians and cut down on duplicate testing, among other things.
Data for stroke, heart and diabetes care indicates that the highest skilled providers routinely prove the most efficient and least costly. |
All member health records should be accumulated in a member
information management unit. Objective information about health outcomes would
facilitate member choices of providers and treatments. Each provider would be
required to provide this information on results, provider experience, methods
and patient attributes. Information should be collected over the full cycle of
care from diagnosis to disease management and prevention. This would reveal the
most skilled diagnosticians and cut down on duplicate testing, among other
thing.
The authors cite Harvard Pilgrim and United Health Group as moving in
this direction. Health plans do not have to do all this in-house. They may
outsource these requirements for highly specialized conditions such as
transplants, end-stage renal disease, infertility treatment, neonatal cardiac
surgery. |
The health plan is in the best position to aggregate data over full
care cycles, and in the best position to help patients navigate the system
through the full care cycle. After all, primary care doctors themselves do not
at present have the data needed to make referral choices. Frequently, all they
have is reputation information.
BCBSMN keeps expanding this program. Chronic conditions account for
about 75% of health care expenditures - a percentage that keeps rising. |
|
Reimbursement policy must not follow that of Medicare "whose flawed reimbursement structure is not aligned with costs, outcomes, or value." |
Risk assessment and disease prevention programs are now being
offered by some health plans. Healthy pregnancy programs are prominent examples.
"When health plans and providers work together around value and health
results, efficiency will improve exponentially and administrative costs will
fall." |
Providers must not be penalized for excellence. They must not be
penalized for better outcomes and less invasive treatment. Quality related
pricing models are being used by such health plans as Harvard Pilgrims and BCBS
of Mass., but these models are currently too limited. "Pay-for-performance
bonuses should be specific to medical conditions, not across the board."
More important than bonuses, however, is an increased flow of referrals and
higher margins from superior outcomes and efficiency.
Much administrative complexity will be eliminated, which will help
balance the costs of increased health plan involvement in the health care
process. Specialist information organizations will arise that enable health
plans to efficiently outsource much of this data collection and analysis effort.
Long term contracts between health plans and subscribers will become an
important feature of full cycle health care medical record keeping. Health plan
structure involving HSAs "can encourage better patient choices while
creating a structure for savings to meet future medical needs." |
|
The
gathering and maintenance of complete subscriber medical records is most
efficiently focused in health plans. Members will
"own" their records, control dissemination, and demand transferal if
they change plans. There are widespread benefits for having complete medical
records available. Service companies are forming to provide medical record
maintenance services. However, appropriate inducement for provider input is
critical.
|
Suppliers, consumers and employers: |
Similar and complimentary
analyses and recommendations are provided by the authors for suppliers,
consumers and employers. & |
Dysfunctional supplier conduct is pervasively dictated by third party payer reimbursement policies.
The adoption of evidence-based medical practice will force suppliers
to concentrate on overall value added rather than just episodic usage.
Suppliers, too, have to begin competing on delivery of unique value over full
care cycles. Me-too products will be revealed as of little value by health care
outcomes data gathered and evaluated by providers and health plans under the
spur of competition. The broader availability of medical information will reveal
the appropriate usage of drugs and devices. The authors provide an analysis of
the shifts in supplier practices required by an evolving value-based competitive
environment. |
Consumers can drive this process by expecting information
relevant to full cycle care outcomes. and by seeking appropriate advice. Health
plans should be chosen based on their commitment to a health care valued added
model of competition and the expectation that treatment will be provided by
physicians who have a record of superior outcomes for each medical
condition.
|
|
The reward for greater quality should usually be more patient volume and higher margins, not higher prices. |
Employers desperately need changes in the current system. Health benefits per employee have risen 140% in ten years to more than $8,400. Health benefit costs add $1,500 to the cost of every American car. The ultimate cost shift is to government and the taxpayer. (This would be a disastrous alternative - resulting in sharply higher taxes without any realistic cost containment mechanism other than the rationing of care.) But cost shifting is the only response most employers know.
An example of new approaches is the Leapfrog Group of major public and private employers that are determined to reduce medical errors. They insist on electronic prescription systems, intensive care physicians available in intensive care units, and provider volume thresholds to assure experienced providers for five high risk surgeries. Clinical process standards are also now required for such surgeries, as is a quality index standard based on National Quality Forum data. A list of qualifying and nonqualifying hospitals is kept on its website. However, all this is predominantly process focused rather than health care outcome focused.
Pay-for-performance models also must shift towards competition on results. "When performance is defined as compliance rather than results, providers and health plans cannot raise their performance metrics with prevention, but only through acute treatment." The reward for greater quality should usually be more patient volume and higher margins, not higher prices.
|
Employers cannot micromanage providers. They should change their
goals from minimizing costs to maximizing health care value. Poor health and
reduced productivity of employees is the cost that should be minimized. |
Government: |
Similar and complimentary analyses and recommendations
are offered by the authors for state and federal governments and their health
plan agencies. & |
"If there is any overarching perspective that has guided public policy, it is government's version of zero-sum competition: drive down the cost of government programs by policing costs, forcing down prices, and shifting costs to the private sector." |
A radical shift of focus in government agency reimbursement regulations is urged by the authors..
|
"Government-run health systems in other parts of the world are encountering increasing problems with quality, costs, and rationing." |
Government run health care is obviously not the answer.
Other nations are currently moving away from the single payer approach,
since it inevitably involves cost shifting and rationing. |
Mandatory health care insurance: |
Universal insurance coverage for "essential
services" with subsidies or vouchers for the poor is advocated by the
authors. & |
However, employer self-insured plans currently represent a large proportion of health plan subscribers, and they are largely free of state regulation. This is the primary defense by which businesses escape some of the cost shifting by government and private health plans. Imposing insurance requirements on the self-insured will require regulatory changes.
|
Over time, employer-sponsored group plans could be phased out with employers required to provide cash amounts for health benefits indexed to inflation. (Health care inflation or general inflation?)
Indeed, the authors propose reporting requirements and higher Medicare and Medicaid taxes for employers that do not provide health benefits. They refer to the Massachusetts plan - still within the state legislative process at the time the book was being published.
|
|
To encourage movement towards value-based competition, the authors then recommend a variety of law and regulatory changes. These include a ban on re-underwriting for sick individuals, and a requirement that health plans be legally responsible for payment of all covered services.
|
|
A good starting point for establishing a minimum coverage standard is the Federal Employee Health Benefits (FEHB) program, the authors suggest. Primary care, preventive care and essential acute care should be included. After that, it gets more complicated.
The Institute of Medicine - an independent group that is part of the National Academy of Science - is currently working on minimum coverage standards. Meanwhile, the standards of the FEHB applicable to Congress and federal employees seem reasonable. Additional coverage could be offered at terms set by competition. |
|
|
After all, everyone who drives is required to have automobile insurance since accidents can impose costs on the public. With today's health care system, the authors argue, everyone can impose costs on the public, so mandatory health insurance is similarly a reasonable requirement.
|
Mandatory coverage is far more efficient and effective than the current system. It would end the use of emergency rooms as the default source of ordinary care for the poor and would encourage all to seek care earlier in disease processes. The self-insured who can afford coverage will begin supporting the system. It would end costly patient dumping and cost shifting practices. Without mandatory coverage, cost shifting to subsidize the poor simply raises prices and drives more people away from coverage.
|
|
Those engaged in risky conduct must pay higher premiums to discourage that conduct and to bear more of the costs, the authors assert. After all, the government, the taxpayer and society now bear major costs for risky conduct,
The authors suggest that higher premiums could be charged for those "who do not accept responsibility for their health." Smokers and those who fail to participate in health screening and prevention programs or disease management programs would be hit with higher premiums. (But the need for health screening varies greatly with age and individual health status. Government can only impose one-size-fits-all requirements.)
|
Personal intimate decisions become suspect even under the current system. The authors note:
Dumping granny's nursing home costs on the government and the taxpayers is a widespread method of gaming the current system, the authors point out.
|
|
End of life care is an especially emotional and costly question.
The authors assert that it
should not be covered beyond what is of proven value "based on demonstrated
results and evidence of patient preference." Living wills establishing each person's preference for
end of life care should be required.
|
Reporting requirements:
& |
A government reporting requirement for results information is the single most important government step in establishing value-based competition on results and will assist all other aspects of the health care system. The authors go at some considerable length in outlining this important procedure.
|
Government should require outcome information by medical condition and
care location, with risk adjustments, and leave other types of information
requirements to the health providers and health plans. Experience with mandates
for transplants, dialysis and cardiac surgery indicates that tasking
professional associations with acquiring the mandated data is superior to
placing the responsibility with a government agency. Medicare has many treatment
quality reporting initiatives under way, but none are focused on results. The
authors suggest several interim measure that would provide quick benefits. They
again emphasize that "reporting must move beyond process compliance and
embrace results measurement."
Improvements in reporting processes can be expected with experience.
Ultimately, when standards for outcome measures and risk adjustments have been
established, outcome reporting for particular medical conditions should become
legally mandatory. It already is for organ transplants, dialysis and in some
states for cardiac surgery. The government also has a role in collecting and
disseminating this data. |
Pricing:
Transparent pricing will generate competition based on value to the patient. |
Prices should cover the full bundle of services and product delivered together for each medical condition. They should not be determined by the patient's "group affiliation." They should be clearly disclosed in advance. This will reduce administrative costs, cost shifting, and incentives for restrictive networks. It will also generate competition based on value to the patient.
|
Barriers: |
A wide variety of barriers to value-based competition have evolved. |
|
|
However, the authors propose some requirements in support of value-based competition.
|
Information technology:
& |
Standards for the interoperability of
hardware and software should be established by government to facilitate a
universal system. Government standards for medical data and for privacy
protection are also needed. Accreditation or Medicare reimbursement requirements
for information technology would expedite adoption of appropriate IT systems. & |
Malpractice Reform: |
Malpractice litigation creates noxious
incentives for defensive medicine and drives up costs for malpractice
insurance. Reforms can include caps on punitive damages awards. It can also
include caps on lawyer contingency fees and sanctions against lawyers for
frivolous suits. (Good Luck!) & |
Medicare: |
Medicare should be transformed into a health plan. It
should no longer be a regulator. & |
Medicare's regulations and third party payer practices have been particularly noxious. However, Medicare is now experimenting with some promising new practices - publishing data comparing hospitals, offering disease management for some medical conditions, paying for counseling to help people stop smoking, providing free medical records software to physicians, and, "more tentatively, recognizing and [rewarding] results and not just processes."
Medicare efforts to administer prices have predictably induced numerous
dysfunctional health care practices. It rewards inputs rather than outputs,
devalues certain services such as consultation, rewards unnecessary diagnostic
and treatment procedures, drastically distorts the health care market,
discourages innovation, among many - many - other things. It works "at
cross purposes to patient value and value improvement."
|
Please return to our Homepage and e-mail your name and comments.
Copyright © 2007 Dan Blatt